Tag: #Global Trends

China’s National Medical Products Administration (NMPA) has granted approvals for two of Sanofi's rare hematologic disease treatments: Qfitlia (fitusiran) and... Read more

Negotiators from the European Parliament (EP) and the EU Council have reached a provisional agreement on a new regulatory framework... Read more

The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Amgen's monoclonal antibody, Uplizna (inebilizumab). The new... Read more

The U.S. Food and Drug Administration (FDA) has announced a decision to expand the usage approval for GSK’s antibiotic, Blujepa,... Read more

EAST HANOVER, December 12, 2025 – The global pharmaceutical corporation Novartis has commenced construction on its major strategic manufacturing center... Read more

Zydus Lifesciences (India) and Formycon AG (Germany) have entered into an exclusive strategic partnership to license and supply FYB206, a... Read more

Novartis, the major pharmaceutical corporation, has signed a multi-program research and development partnership agreement with Relation Therapeutics, an AI-driven biotech... Read more

Moderna, the mRNA specialist, has entered a licensing agreement with Nanexa, a Swedish biotech company, to incorporate tailored release profiles... Read more

Pharmaceutical giant Pfizer is expanding its global cost-cutting agenda, with reports indicating that hundreds of employees in Switzerland are set... Read more